The sad thing about this is that this company really could succeed and bring in a lot of profits for everyone, though it seems as though the ceo may just be screwing us over. That's all it takes to ruin an opportunity like this. I would hold if we could at least maintain around mid 2's, but it seems dilution might kill this over the next month or two before news of the finished animal trials comes. It kills me but I might have to put in my first sell order here in the past 6 months at 22.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.